SKLB610

SKLB610 (订货以CAS编码或英文名称为准)

VEGFR的强效抑制剂,SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays.
创赛科技提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
编号:PC16065
分子式:C21H16N3O3F3
CAS号:1125780-41-7
分子量:415.37
申请试用
货号 品牌 规格 纯度/含量 标准价 优惠价 库存货期 数量 购买
PC16065-5mg Medlife 5mg
≥98%
¥784.00 登录后可见
PC16065-10mg Medlife 10mg
≥98%
¥1470.00 登录后可见
PC16065-50mg Medlife 50mg
≥98%
¥4410.00 登录后可见
PC16065-10mM (in 1mL DMSO) Medlife 10mM (in 1mL DMSO)
≥98%
¥862.40 登录后可见
中文名称: SKLB610
中文别名: N-甲基-4-[4-[3-(三氟甲基)苯甲酰胺基]苯氧基]-2-吡啶甲酰胺;SKLB610 抑制剂;SKLB610
英文名称: SKLB610
英文别名: SKLB610;N-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide 4-methylbenzene sulfonate;SKLB-610;N-Methyl-4-[4-[3-(trifluoromethyl)benzamido]phenoxy]-2-picolinamide
CAS号: 1125780-41-7
分子式: C21H16N3O3F3
分子量: 415.37
详细描述 VEGFR的强效抑制剂,SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays.
搜索质检报告(COA)
相关产品